Related Experiment Videos
Olfml3 Regulates Microglial Inflammation and Neuronal Injury in Obstructive Sleep Apnea via Cybb-Mediated TLR4/NF-κB
Deqiu Kong1, Yaowen Wang1, Xianjun Chen1
1Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Ningbo University, Zhejiang, China.
CNS Neuroscience & Therapeutics
|July 8, 2026
Summary
Olfml3 in microglia protects against obstructive sleep apnea (OSA) by reducing inflammation and neuronal damage. This protein suppresses the Cybb/TLR4/NF-κB pathway, offering neuroprotection in intermittent hypoxia (IH) models.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Obstructive sleep apnea (OSA) is linked to neurocognitive impairment, primarily due to intermittent hypoxia (IH)-induced neuroinflammation.
- Microglia are key players in this IH-induced neuroinflammation, but the role of Olfml3 is not well understood.
Purpose of the Study:
- To investigate the role of Olfml3 in microglia during IH-induced neuroinflammation in OSA.
- To elucidate the molecular mechanisms by which Olfml3 affects microglial activation and neuronal injury.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) and in vitro/vivo OSA models were used.
- Assessed Olfml3 expression, microglial polarization, inflammatory cytokines, reactive oxygen species (ROS), and TLR4/NF-κB pathway activation.
- Evaluated cognitive function, brain pathology, and neuronal injury in mice.
Main Results:
- Olfml3 expression in microglia negatively correlated with Cybb.
- Olfml3 overexpression reduced microglial inflammation and neuronal injury by suppressing the Cybb/TLR4/NF-κB pathway.
- In vivo studies confirmed Olfml3's protective effect against IH-induced neuroinflammation in OSA.
Conclusions:
- Olfml3 in microglia mitigates IH-induced proinflammatory activation and neuronal injury.
- The protective mechanism involves the Cybb/TLR4/NF-κB axis.
- Olfml3 confers neuroprotection against OSA-associated neuroinflammation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...